The University of Oxford’s partnership with AstraZeneca on the development and distribution of Oxford’s COVID-19 vaccine is one of the leaders in this project. AstraZeneca reported it plans to manufacture as much as 30 million doses of the vaccine for…
Moderna’s Preliminary Phase I COVID-19 Vaccine Data Shows Safety and Efficacy
Moderna released positive interim Phase I data from its clinical trial of mRNA-1273, its mRNA vaccine against SARS-CoV-2, the novel coronavirus that causes COVID-19. The vaccine, furthest along in human trials, showed overall positive results for both efficacy and safety.…
Verona says FDA backs plan to take COPD drug into phase 3
More than two years after first saying it would take its lead drug into a pivotal trial, Verona Pharma looks like it may finally follow through on that promise. The UK biopharma says it has received a positive response from…
Takeda posts surprise profit a year after Shire mega-merger
Japan’s Takeda has posted a surprise profit after its $59 billion merger with Shire just over a year ago, as the company shakes off the huge debts it incurred to get the deal done. Analysts had expected Takeda to turn…
Gilead Inks Manufacturing Deals to Make COVID-19 Drug Remdesivir Available in 127 Countries
Currently, Gilead Sciences has the only drug shown to be effective against COVID-19, antiviral drug Veklury (remdesivir). The company has now entered into licensing agreements with five generic drugmakers to make the drug available in 127 countries. They are Mylan,…
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
San Diego-based Sorrento Therapeutics is teaming up with New York City-based Mount Sinai Health System to develop an antibody cocktail called COVI-SHIELD to treat COVID-19. The partnership is aimed at creating antibody products that could act as a “protective shield”…
Japanese regulator approves Gilead’s remdesivir to treat Covid-19
Gilead Sciences has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its antiviral drug remdesivir, under the brand name Veklury, to treat Covid-19 infection. The decision falls under an exceptional approval pathway, which is similar…
Tonix Pharmaceuticals licences three Covid-19 vaccine candidates
Tonix Pharmaceuticals has signed a research collaboration and exclusive licensing agreement with the University of Alberta in Canada for three new vaccine candidates to prevent Covid-19. The partnership will develop the three vaccine candidates, which are based on the horsepox…
US clinical trial sites are most affected due to the Covid-19 pandemic
With over 1,000 trials being disrupted and more trials being added to this category daily, there is a direct impact on trial site activation and patient enrollment. With the recent development of the current Covid-19 pandemic, there has been an…
Ferring’s gut microbiome drug clears phase 3 trial in C. diff
Ferring Pharma has reported what it says is the first positive phase 3 trial of a microbiome therapy – based on healthy bacteria – showing it can reduce recurrences of a serious gastrointestinal infection. The ongoing trial is testing the…
